pefloxacin has been researched along with Mycoplasma dispar Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chidiac, C; Mouton, Y; Senneville, E | 1 |
| Clara, F; Goeddertz, P; Novotna, I; Von Busch, C | 1 |
1 review(s) available for pefloxacin and Mycoplasma dispar Infection
| Article | Year |
|---|---|
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro Techniques; Legionnaires' Disease; Ofloxacin; Pefloxacin; Pneumonia, Mycoplasma | 1992 |
1 other study(ies) available for pefloxacin and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Resistance of Mycoplasma pneumoniae to erythromycin: a clinical case with severe pulmonary, cerebral and systemic complications.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Erythromycin; Female; Fluoroquinolones; Humans; Mycoplasma pneumoniae; Pefloxacin; Pneumonia, Mycoplasma; Treatment Outcome | 1989 |